Inogen (INGN) Current Deferred Revenue (2013 - 2026)

Inogen (INGN) has 14 years of Current Deferred Revenue data on file, last reported at $5.1 million in Q1 2026.

• Current Deferred Revenue for Q1 2026 came in at $5.1 million, down 20.59% year-over-year; the trailing twelve-month figure through Mar 2026 was $5.1 million (down 20.59% YoY), and the FY2025 annual result was $5.5 million, down 17.3% from the prior year.
• Current Deferred Revenue fell to $5.1 million in Q1 2026 per INGN's latest filing, from $5.5 million in the prior quarter.
• Over five years, Current Deferred Revenue peaked at $9.1 million in Q3 2022 and troughed at $5.1 million in Q1 2026.
• A 5-year average of $7.5 million and a median of $7.4 million in 2024 frame the typical range for Current Deferred Revenue.
• The sharpest annual moves came in 2022 and 2026: Current Deferred Revenue climbed 15.98% in 2022, then fell 20.59% in 2026.
• A 5-year view of Current Deferred Revenue shows it stood at $8.9 million in 2022, then retreated by 10.14% to $8.0 million in 2023, then slipped by 16.62% to $6.7 million in 2024, then decreased by 17.3% to $5.5 million in 2025, then fell by 7.5% to $5.1 million in 2026.
• Business Quant data shows INGN's Current Deferred Revenue at $5.1 million in Q1 2026, $5.5 million in Q4 2025, and $6.0 million in Q3 2025.